Mett H - Search Results

1

4-Amidinoindan-1-one 2'-amidinohydrazone: a new potent and selective inhibitor of S-Adenosylmethionine decarboxylase.

Stanek J, Caravatti G, Frei J, Furet P, Mett H, Schneider P, Regenass U. Stanek J, et al. Among authors: mett h. J Med Chem. 1993 Jul 23;36(15):2168-71. doi: 10.1021/jm00067a014. J Med Chem. 1993. PMID: 8340919

2

[(Alkylamino)methyl]acrylophenones: potent and selective inhibitors of the epidermal growth factor receptor protein tyrosine kinase.

Traxler P, Trinks U, Buchdunger E, Mett H, Meyer T, Müller M, Regenass U, Rösel J, Lydon N. Traxler P, et al. Among authors: mett h. J Med Chem. 1995 Jun 23;38(13):2441-8. doi: 10.1021/jm00013a020. J Med Chem. 1995. PMID: 7608909

3

Dianilinophthalimides: potent and selective, ATP-competitive inhibitors of the EGF-receptor protein tyrosine kinase.

Trinks U, Buchdunger E, Furet P, Kump W, Mett H, Meyer T, Müller M, Regenass U, Rihs G, Lydon N, et al. Trinks U, et al. Among authors: mett h. J Med Chem. 1994 Apr 1;37(7):1015-27. doi: 10.1021/jm00033a019. J Med Chem. 1994. PMID: 8151612

4

CGP 48664, a new S-adenosylmethionine decarboxylase inhibitor with broad spectrum antiproliferative and antitumor activity.

Regenass U, Mett H, Stanek J, Mueller M, Kramer D, Porter CW. Regenass U, et al. Among authors: mett h. Cancer Res. 1994 Jun 15;54(12):3210-7. Cancer Res. 1994. PMID: 8205541

5

S-adenosylmethionine decarboxylase inhibitors: new aryl and heteroaryl analogues of methylglyoxal bis(guanylhydrazone).

Stanek J, Caravatti G, Capraro HG, Furet P, Mett H, Schneider P, Regenass U. Stanek J, et al. Among authors: mett h. J Med Chem. 1993 Jan 8;36(1):46-54. doi: 10.1021/jm00053a007. J Med Chem. 1993. PMID: 8421290

6

Pharmacological properties of the ornithine decarboxylase inhibitor 3-aminooxy-1-propanamine and several structural analogues.

Mett H, Stanek J, Lopez-Ballester JA, Jänne J, Alhonen L, Sinervirta R, Frei J, Regenass U. Mett H, et al. Cancer Chemother Pharmacol. 1993;32(1):39-45. doi: 10.1007/BF00685874. Cancer Chemother Pharmacol. 1993. PMID: 8462122

7

4-(Phenylamino)pyrrolopyrimidines: potent and selective, ATP site directed inhibitors of the EGF-receptor protein tyrosine kinase.

Traxler PM, Furet P, Mett H, Buchdunger E, Meyer T, Lydon N. Traxler PM, et al. Among authors: mett h. J Med Chem. 1996 Jun 7;39(12):2285-92. doi: 10.1021/jm960118j. J Med Chem. 1996. PMID: 8691423

8

In vitro trypanocidal activities of new S-adenosylmethionine decarboxylase inhibitors.

Brun R, Bühler Y, Sandmeier U, Kaminsky R, Bacchi CJ, Rattendi D, Lane S, Croft SL, Snowdon D, Yardley V, Caravatti G, Frei J, Stanek J, Mett H. Brun R, et al. Among authors: mett h. Antimicrob Agents Chemother. 1996 Jun;40(6):1442-7. doi: 10.1128/AAC.40.6.1442. Antimicrob Agents Chemother. 1996. PMID: 8726017 Free PMC article.

9

Use of a pharmacophore model for the design of EGF-R tyrosine kinase inhibitors: 4-(phenylamino)pyrazolo[3,4-d]pyrimidines.

Traxler P, Bold G, Frei J, Lang M, Lydon N, Mett H, Buchdunger E, Meyer T, Mueller M, Furet P. Traxler P, et al. Among authors: mett h. J Med Chem. 1997 Oct 24;40(22):3601-16. doi: 10.1021/jm970124v. J Med Chem. 1997. PMID: 9357527

10

2,6,9-trisubstituted purines: optimization towards highly potent and selective CDK1 inhibitors.

Imbach P, Capraro HG, Furet P, Mett H, Meyer T, Zimmermann J. Imbach P, et al. Among authors: mett h. Bioorg Med Chem Lett. 1999 Jan 4;9(1):91-6. doi: 10.1016/s0960-894x(98)00691-x. Bioorg Med Chem Lett. 1999. PMID: 9990463

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters